Summit Therapeutics PLC Stock Performance
as on April 25, 2026 at 2:11 am IST
Day's Low
Day's High
$21.45$22.36
0.42%
Downside
3.81%
Upside
52 Week's Low
52 Week's High
$13.83$36.9135.79%
Downside
71.36%
Upside
Summit Therapeutics PLC share price movements today
- Previous Close
- $22.27
- Open
- $22.22
- Volume
- 2.2M
- Day's Low - High
- $21.45 - $22.36
- 52 Week Low - High
- $13.83 - $36.91
Summit Therapeutics PLC Historical Returns
- 1 Month Return
- + 43.31 %
- 3 Month Return
- + 35.05 %
- 1 Year Return
- -39.32 %
- 3 Year Return
- + 1374.83 %
- 5 Year Return
- + 297.68 %
Summit Therapeutics PLC Stock Fundamentals & Key Indicators
Check Summit Therapeutics PLC market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$19.1B
EPS (TTM)
-0.8758
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-1.1B
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
-206.11%
Summit Therapeutics PLC vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Summit Therapeutics PLC with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $19.1B | 297.68% | NA | 0.00% | |
| BUY | $41.4B | 129.51% | 133.3 | 8.45% | |
| BUY | $111.3B | 99.68% | 28.57 | 32.94% | |
| NA | $33.3B | NA | 121.87 | 5.37% | |
| BUY | $78.9B | 56.77% | 17.99 | 31.41% |
Stock Returns calculator for Summit Therapeutics PLC Stock including INR - Dollar returns
The Summit Therapeutics PLC stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Summit Therapeutics PLC investment value today
Current value as on today
₹64,816
Returns
Returns from Summit Therapeutics PLC Stock
Dollar Impact
₹6,124 (+6.12%)
Analyst Recommendation on Summit Therapeutics PLC Stock
Based on 7 analysts
85.71%
Buy
14.29%
Hold
0.00%
Sell
Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Summit Therapeutics PLC. Average target price of $31.04
Summit Therapeutics PLC Share Price Target
Get share price movements and forecasts by analysts on Summit Therapeutics PLC.
What analysts predicted
30.61%UPSIDE
Target Price
$31.04
Current Price
$21.54
Analyzed by
7 Analysts
Target
$31.04
Summit Therapeutics PLC target price $31.04, a slight upside of 30.61% compared to current price of $21.54. According to 7 analysts rating.
Summit Therapeutics PLC Stock’s Investor Sentiment and Interest
Investment in Summit Therapeutics PLC Shares on INDmoney has grown by 113.20% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:113.20% versus previous 30 day period
Search interest for Summit Therapeutics PLC Stock has increased by 96% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:96% versus previous 30 day period
Summit Therapeutics PLC Quarterly Profit & Loss
All numbers in Millions USD
Summit Therapeutics PLC Annual Profit & Loss
All numbers in Millions USD
Summit Therapeutics PLC Quarterly Cash Flow
All numbers in Millions USD
Summit Therapeutics PLC Annual Cash Flow
All numbers in Millions USD
Summit Therapeutics PLC News & Key Events
Today's Timeline - 09 December
Tue, 09:34 PM
-Concerns rise over Summit's non-oncology growth ahead of Keytruda's exclusivity loss in 2028.
Wed, 03:35 AM
-Summit Therapeutics' ivonescimab shows promise, outperforming Keytruda in lung cancer studies with projected sales of $4.4 billion by 2030.
Insights on Summit Therapeutics PLC
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 3 years, SMMT stock has moved up by 1374.8%
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, SMMT has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -231.79M → -219.17M (in $), with an average increase of 5.8% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 29.3% return, outperforming this stock by 68.6%
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 3 quarters, 235.0K → -235.0K (in $), with an average decrease of 100.0% per quarter
About Summit Therapeutics PLC
| Organisation | Summit Therapeutics PLC |
| Headquarters | 601 Brickell Key Drive, Miami, FL, United States, 33131 |
| Industry | Biotechnology |
| CEO | Dr. Mahkam Zanganeh D.D.S., M.B.A. |
| E-voting on shares | Click here to vote |
Key Management of Summit Therapeutics PLC
Name | Title |
|---|---|
Mr. Robert LaCaze | Chief Commercial Officer |
Dr. Mahkam Zanganeh D.D.S., M.B.A. | Co-CEO, President & Director |
Prof. Kay Elizabeth Davies DBE, FRS CBE | Co-Founder, Chairman of Scientific Advisory Board and Scientific Advisor |
Mr. Bhaskar Anand | Chief Accounting Officer |
Mr. Nathan LiaBraaten | Senior Director of Investor Relations |
Dr. Wang Clow Fong ScD | Chief Biometrics Officer |
Dr. Allen S. Yang M.D., Ph.D. | Head of R&D Strategy |
Dr. Laura Q. M. Chow M.D. | Senior Vice President of Clinical Development |
Mr. Dave Gancarz | Chief Business & Strategy Officer |
Dr. Urte Gayko Ph.D. | Chief Regulatory, Quality & Pharmacovigilance Officer |
FAQs
What is Summit Therapeutics PLC share price today?
Summit Therapeutics PLC share price today is $21.54 as on . Summit Therapeutics PLC share today touched a day high of $22.36 and a low of $21.45.
What is the 52 week high and 52 week low for Summit Therapeutics PLC share?
Summit Therapeutics PLC share touched a 52 week high of $36.91 on and a 52 week low of $13.83 on . Summit Therapeutics PLC stock price today i.e. is trending at $21.54,which is 41.64% down from its 52 week high and 55.75% up from its 52 week low.
What is Summit Therapeutics PLC's market capitalisation today?
Summit Therapeutics PLC market capitalisation is $0.02T as on .
How to invest in Summit Therapeutics PLC Stock (SMMT) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Summit Therapeutics PLC on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Summit Therapeutics PLC Shares that will get you 0.0696 shares as per Summit Therapeutics PLC share price of $21.54 per share as on April 24, 2026 at 8:41 pm IST.
What is the minimum amount required to buy Summit Therapeutics PLC Stock (SMMT) from India?
Indian investors can start investing in Summit Therapeutics PLC (SMMT) shares with as little as ₹94.228 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹942.28 in Summit Therapeutics PLC stock (as per the Rupee-Dollar exchange rate as on ).
Based on Summit Therapeutics PLC share’s latest price of $21.54 as on April 24, 2026 at 8:41 pm IST, you will get 0.4643 shares of Summit Therapeutics PLC. Learn more about
fractional shares .
What are the returns that Summit Therapeutics PLC has given to Indian investors in the last 5 years?
Summit Therapeutics PLC stock has given 297.68% share price returns and 25.07% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?